Literature DB >> 8793255

The study of circulating CD5 positive B lymphocytes in Chinese patients with rheumatoid arthritis.

S T Liu1, C R Wang, M F Liu, J S Li, H Y Lei, C Y Chuang.   

Abstract

Circulating CD5+ B lymphocytes were studied in 39 Chinese patients with rheumatoid arthritis (RA). Blood cells were stained with anti-CD5 and anti-CD19 monoclonal antibodies and were analyzed by flow cytometry. The results showed that there was no elevation of CD5+ B cells in RA patients when compared with 41 healthy control subjects. The circulating levels of CD5+ B cell correlated neither with serum titers of rheumatoid factor (RF) nor with disease activities in these patients. The CD5+ B cell levels remained relatively constant after a serial follow-up for 12 months. The similar pattern of epitope density of CD5 antigens also existed in the same patients. Although most studies in Caucasians revealed increased levels of CD5+ B cells in RA patients, measurements of this marker were not useful for the evaluation of disease activities in Chinese patients. Levels of CD5+ B cells may reflect more individual genetic background and may play a minor role in the flare-up of activities in Chinese patients with RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793255     DOI: 10.1007/bf02229702

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice.

Authors:  M Murakami; T Tsubata; M Okamoto; A Shimizu; S Kumagai; H Imura; T Honjo
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

2.  Human normal CD5+ B lymphocytes can be induced to differentiate to CD5- B lymphocytes with germinal center cell features.

Authors:  F Caligaris-Cappio; M Riva; L Tesio; M Schena; G Gaidano; L Bergui
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

3.  Genetic influence on the levels of circulating CD5 B lymphocytes.

Authors:  T J Kipps; J H Vaughan
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

4.  Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases.

Authors:  J A Sowden; P J Roberts-Thomson; H Zola
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

5.  Estimation of serum V kappa IIIb light chains in rheumatoid arthritis and correlation with CD5-positive B-cells.

Authors:  H B Smalley; J Todd; R M Barnes; R N Thompson; G N Abraham; P M Johnson
Journal:  Br J Rheumatol       Date:  1990-10

6.  Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset.

Authors:  P Casali; S E Burastero; M Nakamura; G Inghirami; A L Notkins
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

7.  Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity.

Authors:  J N Jarvis; J Kaplan; N Fine
Journal:  Arthritis Rheum       Date:  1992-02

8.  Comparative evaluation of CD5 B cells in patients with rheumatoid arthritis and essential mixed cryoimmunoglobulinemia using FACS analyzer and FACSCAN flow cytometer.

Authors:  H J Xu; P J Roberts-Thomson; M J Ahern; H Zola
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

9.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

Authors:  J H Antin; S G Emerson; P Martin; N Gadol; K A Ault
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes.

Authors:  T J Mercolino; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.